Business
Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading
LYON, France, July 29, 2025--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today provides an update on its ongoing negotiations with its creditors and its agreement with its senior creditor, IPF Partners, to file for insolvency (déclaration de cessatio
About this update from Poxel Sa
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":256,"url":"https://media.zenfs.com/en/business-wire.com/c91ce3278fb6197008c8fe2dff09f776"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0xIlRU8KMsupcnUaQXHGLg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUxMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c91ce3278fb6197008c8fe2dff09f776","width":480,"height":256}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Since the rejection of key financial delegations during its Shareholders General Meeting of February 11, 2025, triggering a case of default of certain of its existing debts, Poxel’s management has held discussions with the Company’s creditors.","length":243,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Poxel’s proposed plan including a partnership and sale for one of its pipeline product together with potential additional financing, could not materialize within a foreseeable timeframe.","length":186,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Consequently, Poxel and IPF Partners have agreed on a transition plan which includes the following steps:","length":105,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Filing by Poxel for insolvency (déclaration de cessation des paiements) and requesting the opening of reorganization proceedings (redressement judiciaire) to the Court for Economic Activities of Lyon;","length":200,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Upcoming replacement of all current members of the Board of Directors following their individual resignation;","length":109,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Upcoming announcement of a new executive management team to replace the current CEO; and","length":88,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Implementation of a short-term operational and financial transition plan to ensure continuity of operations.","length":108,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":505,"olType":false}]},{"val":[{"type":"text","content":"Implementation of the steps of this transition plan will be announced as soon as it is effective.","length":97,"tagName":"p","attribs":{}}]},{"val":[{"t...